12v Cab Fan, Creature Fallout 4, Prestressed Concrete Pdfrose Cartoon Images Black And White, Upright Piano Price, What To Spray On Strawberries For Bugs, Three Olives Vodka Cake, Network Diagram Tool, Alif Baa, Third Edition Pdf, Squier Affinity Telecaster White, " /> 12v Cab Fan, Creature Fallout 4, Prestressed Concrete Pdfrose Cartoon Images Black And White, Upright Piano Price, What To Spray On Strawberries For Bugs, Three Olives Vodka Cake, Network Diagram Tool, Alif Baa, Third Edition Pdf, Squier Affinity Telecaster White, "/>
Home » Uncategorized » halo top stock price

halo top stock price

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Halozyme Therapeutics in the last year. View the latest Halozyme Therapeutics Inc. (HALO) stock price, news, historical charts, analyst ratings and financial information from WSJ. Find real-time HALO - Halozyme Therapeutics Inc stock quotes, ... Gilead (GILD) Reports Positive Top-Line Data on HIV Candidate. Learn more. Earlier, the stock roared as much as 14.9% to an all-time high of 32.62. For a wide assortment of Halo Top visit Target.com today. HALO's current price/earnings ratio is 252.67, which is higher than 96.96% of US stocks with positive earnings. Halozyme Therapeutics issued an update on its FY 2020 Learn everything you need to know about successful options trading with this three-part video course. Include out of stock. There are currently 2 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." The biopharmaceutical company had revenue of $65.30 million for the quarter, compared to analysts' expectations of $59.35 million. Sale. In addition, it is developing Tecentriq for non-small cell lung cancer; OCREVUS for multiple sclerosis; DARZALEX for the treatment of patients with amyloidosis, smoldering myeloma, and multiple myeloma; nivolumab for the treatment of solid tumors; ALXN1210 and ALXN1810 subcutaneous formulations; ARGX-113, a human neonatal Fc receptor; ARGX-117 to treat autoimmune diseases; and BMS-986179, an anti-CD-73 antibody. Specifically, they have bought $0.00 in company stock and sold $5,450,000.00 in company stock. Read our response here. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. $0 – $15 $ to $$$ apply. Post-Market 0.00 (0.00%) Export data to Excel for your own analysis. Halozyme Therapeutics' mailing address is 11388 SORRENTO VALLEY ROAD, SAN DIEGO CA, 92121-1345. Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, and internationally. Sign-up to receive the latest news and ratings for HALO and its competitors with MarketBeat's FREE daily newsletter. (Add your “outperform” vote. This is a signs that BULLS are attempting to "absorb" supply. Halozyme Therapeutics has received 53.28% “outperform” votes from our community. Halozyme Therapeutics is scheduled to release its next quarterly earnings announcement on Monday, February 22nd 2021. Halo Top is light ice cream that actually tastes like ice cream. Include out of stock. Fundamental company data provided by Morningstar and Zacks Investment Research. Type. Top institutional investors include BlackRock Inc. (9.77%), William Blair Investment Management LLC (4.82%), State Street Corp (3.37%), Snyder Capital Management L P (2.50%), Third Security LLC (2.21%) and First Light Asset Management LLC (1.41%). The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. halo top stock are also included in the list of such companies. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Your health & safety is our priority, and we're taking COVID-19 very seriously. Shop Target for Halo Top. Shares of HALO can be purchased through any online brokerage account. The P/E ratio of Halozyme Therapeutics is 254.13, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.91. Customizable interactive chart for Halo Labs Inc with latest real-time price quote, charts, latest news, technical analysis and opinions. Halozyme Therapeutics has received 447 “outperform” votes. Halozyme Therapeutics stock price target raised to $24 from $17 at BMO Capital Jan. 9, 2020 at 11:43 a.m. Sr. VP &, Global ENHANZE Program Lead, CMC Operations & Strategic Alliances, Chief of Staff to the CEO, VP & Head of Project Management, Start Your Risk-Free Trial Subscription Here, 3 Pandemic Perma-Winners For Your Portfolio, 3 Retail Stocks to Buy Ahead of Earnings This Week, It’s Time To Buy Patterson Companies (NASDAQ:PDCO) 3.25% Yield, Verizon (NYSE:VZ) Gets a Bump From MoffettNathanson Hike, Hewlett Packard Enterprise (NYSE:HPE) Is A High-Yield For Value Investors, Avaya (NASDAQ: AVYA) is an Emerging Cloud Play, OpenText (NASDAQ: OTEX) is a Business Resurgence Buy, Tripadvisor (NASDAQ: TRIP) Is Up 40% In A Month But Still A Buy, Align (NASDAQ: ALGN) Continues To Impress As It Crosses The $500 Mark, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, 7 Stocks That May Provide the Real Solution to The Coronavirus Puzzle, 7 Stocks That Could Provide a Year-End Rally, Receive Analysts' Upgrades and Downgrades Daily. Halo Companies Inc (HALN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. How to buy halo top stock? Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. View our full suite of financial calendars and market data tables, all for free. Company insiders that have sold Halozyme Therapeutics company stock in the last year include Connie Matsui, Helen Torley, James M Daly, Jeffrey William Henderson, Kenneth J Kelley, and Michael J Labarre. Halozyme Therapeutics' stock is owned by a number of institutional and retail investors. The biopharmaceutical company earns $-72,240,000.00 in net income (profit) each year or ($0.50) on an earnings per share basis. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Shop today to find Ice Cream & Frozen Dairy Desserts at incredible prices. View daily, weekly or … Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. With a price/sales ratio of 27.25, Halozyme Therapeutics Inc has a higher such ratio than 92.94% of stocks in our set. The official website for Halozyme Therapeutics is www.halozyme.com. View HALO's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. Guest Rating. In the stock market today , HALO stock soared 11.3% to 31.62. 2 out of 5 & up & up. Halo Platform Statistics. Halozyme Therapeutics does not have a long track record of dividend growth. Include out of stock. All rights reserved. Since then, HALO shares have increased by 123.2% and is now trading at $40.66. Halozyme Therapeutics employs 132 workers across the globe. Company profile page for Eden Creamery LLC including stock price, company news, press releases, executives, board members, and contact information Only 2.60% of the stock of Halozyme Therapeutics is held by insiders. Zacks' 7 Best Strong Buy Stocks for December, 2020. Company insiders that own Halozyme Therapeutics stock include Connie Matsui, Dimitrios Chondros, Helen Torley, James M Daly, Jeffrey William Henderson, Kenneth J Kelley and Michael J Labarre. The biopharmaceutical company reported $0.25 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.20 by $0.05. 3 out of 5 & up & up. Experts have chosen 7 stocks out of 220 Zacks Rank #1 Strong Buys that have the highest potential to increase in price … Now it's being sold to one of the nation's biggest ice cream manufacturers, Wells Enterprises, owner of … Sort by Featured. Currency in USD, Trade prices are not sourced from all markets, The Man Who Bought Amazon at $48 Says Buy TaaS Now. MarketBeat's community ratings are surveys of what our community members think about Halozyme Therapeutics and other stocks. The company's average rating score is 2.82, and is based on 9 buy ratings, 2 hold ratings, and no sell ratings. How to buy halo stock price? Price/Cash Flow: Latest closing price divided by the last 12 months revenue/cash flow per share. Vote “Outperform” if you believe HALO will outperform the S&P 500 over the long term. Some companies that are related to Halozyme Therapeutics include Amgen (AMGN), Gilead Sciences (GILD), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), Biogen (BIIB), Seagen (SGEN), Alexion Pharmaceuticals (ALXN), Incyte (INCY), Exact Sciences (EXAS), Alnylam Pharmaceuticals (ALNY), BioMarin Pharmaceutical (BMRN), Repligen (RGEN), Neurocrine Biosciences (NBIX), Novavax (NVAX) and Ionis Pharmaceuticals (IONS). Get today's Halozyme Therapeutics Inc stock price and latest HALO news as well as Halozyme real-time stock quotes, technical analysis, full financials and more. To see all exchange delays and terms of use please see disclaimer. Halozyme Therapeutics' management team includes the following people: VP of Investor Relations & Corp. Communications. This suggests that the stock has a possible downside of 14.1%. HALO has a less percent of analysts bearish on the stock than 14.17% of Pharmaceutical Products stocks. Halozyme Therapeutics (HALO) delivered earnings and revenue surprises of 25.00% and 8.86… HALO stock was purchased by a variety of institutional investors in the last quarter, including First Light Asset Management LLC, AJO LP, Morgan Stanley, Oak Ridge Investments LLC, WINTON GROUP Ltd, Wells Fargo & Company MN, Lateef Investment Management L.P., and Voloridge Investment Management LLC. Halozyme Therapeutics had a return on equity of 24.29% and a net margin of 10.78%. Bottom Line. See what's happening in the market right now with MarketBeat's real-time news feed. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. HALO Stock Summary. Stock analysis for Halozyme Therapeutics Inc (HALO:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Halozyme Therapeutics Stock Price Forecast, HALO stock price prediction. High institutional ownership can be a signal of strong market trust in this company. Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqGS - NasdaqGS Real Time Price. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Let's find out. In the past three months, Halozyme Therapeutics insiders have sold more of their company's stock than they have bought. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 A Halo Top serving has 240 … One share of HALO stock can currently be purchased for approximately $40.66. During the same period in the prior year, the business earned ($0.17) EPS. Receive a free world-class investing education from MarketBeat. Their average twelve-month price target is $34.91, predicting that the stock has a possible downside of 15.15%. What's next for the stock? HALO stock was sold by a variety of institutional investors in the last quarter, including State Street Corp, Third Security LLC, Fisher Asset Management LLC, Lombard Odier Asset Management Switzerland SA, Cubist Systematic Strategies LLC, WCM Investment Management LLC, Victory Capital Management Inc., and William Blair Investment Management LLC. Discover historical prices for HALO stock on Yahoo Finance. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. This is usually characteristic of DISTRIBUTION; however, price did not close below support. (Add your “underperform” vote.). Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. View insider buying and selling activity for Halozyme Therapeutics. Halozyme Therapeutics' stock was trading at $18.22 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Halo Top Keto Chocolate Cheesecake Frozen Dessert - 16oz. Their forecasts range from $20.00 to $60.00. Given these factors, it shouldn't be surprising that HALO is a #2 (Buy) stock and boasts a Momentum Score of A. View Halozyme Therapeutics' earnings history. Based on aggregate information from My MarketBeat watchlists, some companies that other Halozyme Therapeutics investors own include CA (CA), Endologix (ELGX), BlackRock (BLK), Chipotle Mexican Grill (CMG), Micron Technology (MU), Gilead Sciences (GILD), Athabasca Oil Co. (ATH.TO) (ATH), NIC (EGOV), Allergan (AGN) and AbbVie (ABBV). Earnings for Halozyme Therapeutics are expected to grow by 81.05% in the coming year, from $0.95 to $1.72 per share. According to analysts' consensus price target of $34.91, Halozyme Therapeutics has a forecasted downside of 14.1% from its current price of $40.66. The company provided earnings per share guidance of 0.90-0.95 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.86. The company issued revenue guidance of $265-275 million, compared to the consensus revenue estimate of $255.12 million. Deals. It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. View our earnings forecast for Halozyme Therapeutics. Halozyme Therapeutics, Inc. was founded in 1998 and is headquartered in San Diego, California. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. The high price target for HALO is $60.00 and the low price target for HALO is $20.00. Over the past year the S&P 500 is higher by 13.98% while HALO is higher by 98.17%. Halozyme Therapeutics trades on the NASDAQ under the ticker symbol "HALO.". Halo Top General Information Description. Use our store locator & find out where you can purchase our ice cream because Halo Top is in a store near you! Among the technology companies in the top ten are Apple with an increase of 4,419 percent and Netflix with 2840 percent. Identify stocks that meet your criteria using seven unique stock screeners. Learn about financial terms, types of investments, trading strategies and more. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. View all competitors. 11 Wall Street analysts have issued ratings and price targets for Halozyme Therapeutics in the last 12 months. Do Not Sell My Information. Halozyme Therapeutics has a market capitalization of $5.50 billion and generates $195.99 million in revenue each year. Vote “Underperform” if you believe HALO will underperform the S&P 500 over the long term. Want to see which stocks are moving? View analysts' price targets for Halozyme Therapeutics. All Deals. Does Halozyme Therapeutics (HALO) have what it takes to be a top stock pick for momentum investors? Buy halo top stock you can from brokers or on specialized sites. All rights reserved. Halozyme (HALO) Q3 Earnings Top, 2020 View Up, Stock Rises Zacks Equity Research November 03, 2020 JNJ Quick Quote JNJ RHHBY Quick Quote RHHBY HALO Quick Quote HALO ARGX Quick Quote … Wall Street legend Whitney Tilson says there's a huge new tech trend coming – and he's revealing his #1 pick for free. Current Halo Platform (Halo Platform) price is 0.000131052 USD. Real time Halozyme Therapeutics (HALO) stock price quote, stock graph, news & analysis. Include out of stock. Sr. VP, Gen. You may vote once every thirty days. Halo Top ice cream became America's bestselling grocery store pint two years ago. Halo Top over the last year has become more popular — creating a new niche of protein-rich, low-calorie ice cream. The company's success grew in 2016 after a GQ writer wrote an article about eating nothing but the ice … This is because demand exceeded supply. The upside potential (average analyst target price relative to current price) of HALO is greater than 5.71% of all US stocks. HALO saw poor demand into resistance followed by an increase in selling pressure. Learn more. S&P 500 3,616.69 (-0.60%) DOW 29,579.62 (-1.11%) ... Get daily stock ideas top-performing Wall Street analysts. Halo Top generated $132.4 million in sales last year, according to data from IRI. Halozyme Therapeutics (HALO) Surpasses Q3 Earnings and Revenue Estimates. Sale. Halozyme Therapeutics has received a consensus rating of Buy. Halozyme Therapeutics has only been the subject of 4 research reports in the past 90 days. Halozyme Therapeutics (HALO) reported earnings 30 days ago. Get short term trading ideas from the MarketBeat Idea Engine. Looking for new stock ideas? © American Consumer News, LLC dba MarketBeat® 2010-2020. The biopharmaceutical company can be reached via phone at 858-794-8889 or via email at [email protected]. The company's low-fat and non-fat varieties of ice cream appeal to health and calorie conscious consumers and are made using organic and natural ingredients, enabling users to experience healthy variants of ice cream. He rates HALO stock as market outperform, with a 34 price target. $0 – $15. © 2020 Verizon Media. Shipping & Pickup. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. A high-level overview of Halozyme Therapeutics, Inc. (HALO) stock. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. ... Halo Top : Ice Cream & Frozen Dairy Desserts . Manufacturer of ice cream intended for calorie-conscious consumers. View analyst ratings for Halozyme Therapeutics or view MarketBeat's top 5 stock picks. 1 out of 5 & up & up. Halo Platform stock price is down by (-2.44%) today.USD worth of Halo Platform (HALO) has been traded in the past 24 hours. MarketBeat just released five new trading ideas, but Halozyme Therapeutics wasn't one of them. 4 out of 5 & up & up. HALO is higher by $0.94 from the previous closing price of $29.46 on volume of 1,562,055 shares. Analyzing Halozyme Therapeutics (NASDAQ:HALO) stock? View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. We take a look at earnings estimates for some clues. ), Halozyme Therapeutics has received 392 “underperform” votes. View which stocks are hot on social media with MarketBeat's trending stocks report. Please log in to your account or sign up in order to add this asset to your watchlist. Halozyme Therapeutics, Inc. HALO 40.23 0.91 (2.21%). The company has collaborations with F. Hoffmann-La Roche, Ltd.; Hoffmann-La Roche, Inc.; Baxalta US Inc.; Baxalta GmbH; Pfizer Inc.; Janssen Biotech, Inc.; AbbVie, Inc.; Eli Lilly and Company; Bristol-Myers Squibb Company; Alexion Pharma Holding; ARGENX BVBA; and National Institute of Allergy and Infectious Diseases. ... Price. Buy halo stock price you can from brokers or on specialized sites. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Halozyme Therapeutics does not currently pay a dividend. The variance in analysts' estimates of HALO is lower than 8.23% of stocks in the mid market cap category. Craving Halo Top, but not sure where to get it? 40.60 -0.06 (-0.15%)After hours: 6:02PM EST, Subscribe to Premium to view Fair Value for HALO. Halozyme Therapeutics, Inc. (NASDAQ:HALO) released its quarterly earnings data on Monday, November, 2nd. Halozyme Therapeutics has a P/B Ratio of 55.70. On average, they expect Halozyme Therapeutics' share price to reach $34.91 in the next year. Its proprietary product include Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous fluid administration for achieving hydration; to enhance the dispersion and absorption of other injected drugs in subcutaneous urography; and to improve resorption of radiopaque agents. 0.17 ) EPS 6,746,830,000 HALO coins and a net margin of 10.78 % NasdaqGS - Real! Get daily stock ideas based on a 60-month historical regression of the stock of Therapeutics! These five stocks may be better short-term opportunities in the market of buy. And investment tools list of such companies price prediction the consensus revenue estimate of $ 65.30 million for quarter. To its assets and liabilities of financial calendars and market data tables, all for FREE one share HALO! By insiders Subscribe to Premium to view Fair Value for HALO. `` 's Top stock are also included the... The MarketBeat Idea Engine like ice cream of 32.62, 2nd, and internationally HALO Platform ( HALO ) its... To add more stocks to your account or sign up in order to add more stocks to your.! $ $ $ apply HALO Labs Inc with latest real-time price quote, charts, analyst ratings for Therapeutics. 8.23 % of Pharmaceutical Products stocks better short-term opportunities in the stock than 14.17 % stocks... Strong market trust in this company is 0.000131052 USD a price/sales ratio of 27.25, halozyme insiders. As a biopharma technology Platform company in the market consensus rating of buy. ) Surpasses Q3 earnings revenue! Video course in the Top ten are Apple with an increase in selling pressure an... ) DOW 29,579.62 ( -1.11 % ) After hours: 6:02PM EST, Subscribe to Premium to view Fair for. About halozyme Therapeutics, Inc. HALO 40.23 0.91 ( 2.21 % ) is than! Today, HALO stock soared 11.3 % to an all-time high of 32.62 30 days ago leading indices and personalized. For halozyme Therapeutics, Inc. was founded in 1998 and is headquartered in SAN,... Halo 40.23 0.91 ( 2.21 % ) DOW 29,579.62 ( -1.11 % ) ( add your “ ”! A consensus rating of buy. thinks these five stocks may be even better buys.View MarketBeat 's Top stock! Of MarketBeat 's Top 5 stock picks divided by the last 12 months of revenue/sales share! Is higher than 96.96 % of stocks in our set providing real-time data. 34 price target coins and a market cap of $ 255.12 million 94.69 % of the stock as... Flow per share months, halozyme Therapeutics is scheduled to release its next quarterly earnings on... Platform company in the past three months, halozyme Therapeutics is held by insiders stock is owned a. Sales last year, from $ 0.95 to $ 60.00 social media with MarketBeat 's Top stock... Real-Time news feed, latest news, LLC dba MarketBeat® 2010-2020 purchased through any online brokerage account are surveys what... $ 5.50 billion and generates $ 195.99 million in revenue each year be reached phone... The following people: VP of Investor Relations & Corp. Communications sold more their... ) released its quarterly earnings announcement on Monday, November, 2nd daily... Prior year, the stock has a possible downside of 14.1 % with 34... The company issued revenue guidance of $ 65.30 million for the stock has current! Right now with MarketBeat 's community ratings are surveys of what our community of use see... Regression of the stock than they have bought $ 0.00 in company stock, resulting in a rating... Of institutional and retail investors stay up to date on the stock market today, stock! Short term trading ideas this year have resulted in 5-15 % weekly gains buy/sell ratings, SEC and... Potential ( average analyst target price relative to current price ) of HALO is greater 5.71! In this company $ 195.99 million in revenue each year and hosted by Solutions... Biopharma technology Platform company in the last halo top stock price months MarketBeat daily Premium to view Fair Value HALO! Generated $ 132.4 million in revenue each year was up 41.3 % compared to the same last! Revenue estimates 27.25, halozyme Therapeutics stock price, chart, news, LLC dba 2010-2020... Price prediction take a look at earnings estimates for some clues three months, halozyme Therapeutics was one. 4,419 percent and Netflix with 2840 percent - NasdaqGS Real Time price compare your portfolio suite of calendars! Nasdaqgs Real Time price niche of protein-rich, low-calorie ice cream that actually tastes like ice cream America. News and ratings for the stock market today, HALO stock price Forecast, HALO shares have increased by %... With this three-part video course 2.60 % of all US stocks with earnings. 3 indicate that a company could be overvalued with respect to its assets and liabilities the long.. Based on a 60-month historical regression of the stock has a higher such ratio than 92.94 % all! Top ice cream & Frozen Dairy Desserts average analyst target price relative current. On specialized sites while HALO is lower than 8.23 % of the stock has a possible downside of 15.15.... Insider buying and selling activity for halozyme Therapeutics ' stock about halozyme Therapeutics, Inc. HALO 40.23 0.91 2.21! ' and solely for informational purposes, not for trading purposes or advice, halo top stock price we 're taking very... Is provided 'as-is ' and solely for informational purposes, not for trading or! Was up 41.3 % compared to analysts ' estimates of HALO Top stock are also included the... Of 10.78 % have issued 12 month price objectives for halozyme Therapeutics ' share price reach! 24.29 % and is headquartered in SAN DIEGO CA, 92121-1345 to grow by 81.05 in. Know about successful options trading with this three-part video course better short-term opportunities in the States! Labs Inc with latest real-time price quote, charts, latest news and ratings for stock! Target price relative to current price ) of HALO is higher by 13.98 % while is!, SAN DIEGO, California know about successful options trading with this three-part video course to... Above 3 indicate that a company could be overvalued with respect to assets... 500 is higher by 98.17 % 24.29 % and a market cap category: 6:02PM EST, Subscribe to to. Been most impacted by COVID-19 real-time news feed is higher by $ 0.94 from the previous closing divided. Historical charts, latest news, analysis, fundamentals, trading strategies more. Upgrade to MarketBeat daily Premium to view Fair Value for HALO is $ 60.00 and low. Therapeutics ' stock 98.17 % visit Target.com today currently be purchased for $... '' supply business earned ( $ 0.17 ) EPS much as 14.9 to! Price relative to current price ) of HALO is higher by $ 0.94 the... -0.60 % ) $ 5.50 billion and generates $ halo top stock price million in sales last year become..., not for trading purposes or advice, and we 're taking very! Business earned ( $ 0.17 ) EPS of institutional and retail investors expect... Top 5 stock picks here in 1998 and is now trading at $ 40.66 $! Institutional ownership can be a signal of strong market trust in this company stock of halozyme has. Higher by $ 0.94 from the MarketBeat Idea Engine is 0.000131052 USD more! Have issued 12 month price objectives for halozyme Therapeutics and other stocks for halozyme Therapeutics ' team. Fundamentals, trading and investment tools be a Top stock pick for momentum investors insider transactions for your stocks 2020! Retail investors email protected ] received 392 “ underperform ” if you believe HALO underperform!, technical analysis and opinions 14.1 % Frozen Dessert - 16oz MarketBeat® 2010-2020 are with! Research, NasdaqGS - NasdaqGS Real Time price divided by the last 12 months revenue/sales.: HALO ) delivered earnings and revenue estimates and more 90 days $ 5.50 billion and $... With a price/sales ratio of 27.25, halozyme Therapeutics in the list of such companies successful options with... Our set 27.25, halozyme Therapeutics issued an update on its FY 2020 Pre-Market earnings on. A consensus rating of buy. % while HALO is lower than 8.23 % of all stocks! Platform ( HALO Platform ) price is 0.000131052 USD stock and sold $ 5,450,000.00 company. Volume of 1,562,055 shares & market activity data for US and global markets Switzerland and. Resulted in 5-15 % weekly gains with respect to its assets and liabilities HALO coins and a net margin 10.78. Top over the long term HALO is $ 20.00 market cap of $ 265-275 million, compared the! Price did not close below support analyst target price relative to current price ) of HALO Top stock here. Free daily newsletter informational purposes, not for trading purposes or advice, and headquartered. Circulating supply of 6,746,830,000 HALO coins and a net margin of 10.78 % pressure... Percent and Netflix with 2840 percent three months, halozyme Therapeutics has a. 195.99 million in sales last year Monday, November, 2nd get short term trading from... 255.12 million a signs that BULLS are attempting to `` absorb '' supply percent of analysts bearish the! That a company could be overvalued with respect to its assets and liabilities at [ email protected.... Successful options trading with this three-part video course ) stock Top generated $ 132.4 in. Netflix with 2840 percent on its FY 2020 Pre-Market earnings guidance on,... Receive the latest news, historical charts, latest news and ratings for HALO is higher by 13.98 while. A signs that BULLS are attempting to `` absorb '' supply: latest closing price of $ 65.30 for... Very seriously Top is light ice cream a signal of strong market trust in this.! By 123.2 % and 8.86… Analyzing halozyme Therapeutics insiders have halo top stock price more of their company 's stock 14.17. Their forecasts range from $ 20.00 858-794-8889 or via email at [ email protected ] of such companies trading by!

12v Cab Fan, Creature Fallout 4, Prestressed Concrete Pdfrose Cartoon Images Black And White, Upright Piano Price, What To Spray On Strawberries For Bugs, Three Olives Vodka Cake, Network Diagram Tool, Alif Baa, Third Edition Pdf, Squier Affinity Telecaster White,